PROVIDENCE – Richard A. Andrews has been appointed chief operating officer at ProThera Biologics. The company is developing inter-alpha inhibitor proteins to treat severe inflammation associated with infection, trauma and disease. In his new role, Andrews will work directly with President and Chief Business Officer Denice Spero and CEO Yow-Pin Lim to advance the company’s…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.